Latest period
$269.60M
YoY change
+8.7%
5Y CAGR
+10.8%
Peak year (2021)
$307.86M
Latest annual
$256.55M
Free Cash Flow history chart for Bio-Techne (TECH) from 1990 to 2025
Latest: $256.55M
Free Cash Flow growth chart for Bio-Techne (TECH) from 1990 to 2025
Latest: +8.7%
Free Cash Flow history table for Bio-Techne (TECH) from 1990 to 2025
| 2025 | $256.55M | +8.7% | +$20.45M | ||
| 2024 | $236.10M | +9.2% | +$19.95M | ||
| 2023 | $216.15M | -22.9% | −$64.22M | ||
| 2022 | $280.36M | -8.9% | −$27.50M | ||
| 2021 | $307.86M | +100.6% | +$154.39M | ||
| 2020 | $153.47M | -1.8% | −$2.73M | ||
| 2019 | $156.21M | +4.5% | +$6.78M | ||
| 2018 | $149.43M | +16.5% | +$21.16M | ||
| 2017 | $128.27M | +1.0% | +$1.30M | ||
| 2016 | $126.97M | +6.3% | +$7.52M | ||
| 2015 | $119.45M | -2.8% | −$3.49M | ||
| 2014 | $122.94M | +21.6% | +$21.83M | ||
| 2013 | $101.11M | -16.3% | −$19.62M | ||
| 2012 | $120.73M | -2.3% | −$2.83M | ||
| 2011 | $123.56M | +15.9% | +$16.95M | ||
| 2010 | $106.62M | +1.8% | +$1.85M | ||
| 2009 | $104.77M | +5.9% | +$5.81M | ||
| 2008 | $98.95M | +20.0% | +$16.52M | ||
| 2007 | $82.43M | +1.8% | +$1.44M | ||
| 2006 | $80.99M | +28.5% | +$17.96M | ||
| 2005 | $63.02M | +1.9% | +$1.18M | ||
| 2004 | $61.84M | +59.0% | +$22.95M | ||
| 2003 | $38.90M | +621.5% | +$33.50M | ||
| 2002 | $5.39M | -86.4% | −$34.17M | ||
| 2001 | $39.56M | +372.5% | +$31.19M | ||
| 2000 | $8.37M | -480.5% | +$10.57M | ||
| 1999 | −$2.20M | -112.7% | −$19.50M | ||
| 1998 | $17.30M | +108.4% | +$9.00M | ||
| 1997 | $8.30M | +144.1% | +$4.90M | ||
| 1996 | $3.40M | -43.3% | −$2.60M | ||
| 1995 | $6.00M | +20.0% | +$1.00M | ||
| 1994 | $5.00M | +163.2% | +$3.10M | ||
| 1993 | $1.90M | -42.4% | −$1.40M | ||
| 1992 | $3.30M | +266.7% | +$2.40M | ||
| 1991 | $900.00K | +28.6% | +$200.00K | ||
| 1990 | $700.00K | — | — |
- 2025$256.55M+8.7%
- 2024$236.10M+9.2%
- 2023$216.15M-22.9%
- 2022$280.36M-8.9%
- 2021$307.86M+100.6%
- 2020$153.47M-1.8%
- 2019$156.21M+4.5%
- 2018$149.43M+16.5%
- 2017$128.27M+1.0%
- 2016$126.97M+6.3%
- 2015$119.45M-2.8%
- 2014$122.94M+21.6%
- 2013$101.11M-16.3%
- 2012$120.73M-2.3%
- 2011$123.56M+15.9%
- 2010$106.62M+1.8%
- 2009$104.77M+5.9%
- 2008$98.95M+20.0%
- 2007$82.43M+1.8%
- 2006$80.99M+28.5%
- 2005$63.02M+1.9%
- 2004$61.84M+59.0%
- 2003$38.90M+621.5%
- 2002$5.39M-86.4%
- 2001$39.56M+372.5%
- 2000$8.37M-480.5%
- 1999−$2.20M-112.7%
- 1998$17.30M+108.4%
- 1997$8.30M+144.1%
- 1996$3.40M-43.3%
- 1995$6.00M+20.0%
- 1994$5.00M+163.2%
- 1993$1.90M-42.4%
- 1992$3.30M+266.7%
- 1991$900.00K+28.6%
- 1990$700.00K—
Free Cash Flow values are taken from Bio-Techne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Bio-Techne (TECH)
Free Cash Flow for Bio-Techne (TECH): headline value $269.60M · YoY +8.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Bio-Techne (TECH) reported free cash flow of $256.55M – grew 8.7% year-over-year.
Bio-Techne free cash flow compound annual growth for the 2020–2025 (5 years) window is +10.8%, sustaining 2 straight years of year-over-year growth.
Bio-Techne free cash flow peaked at $307.86M in 2021; the latest annual figure is $256.55M in 2025 (16.7% below peak).
2021 marks the peak free cash flow at $307.86M, with the historical low of −$2.20M recorded in 1999.
Bio-Techne Free Cash Flow by Year
Bio-Techne Free Cash Flow 2025: $256.55M
Bio-Techne posted free cash flow of $256.55M in 2025, grew 8.7% from 2024.
Bio-Techne Free Cash Flow 2024: $236.10M
In 2024, Bio-Techne reported free cash flow of $236.10M, grew 9.2% from 2023.
Bio-Techne Free Cash Flow 2023: $216.15M
Bio-Techne free cash flow in 2023 was $216.15M, declined 22.9% below 2022.
Bio-Techne Free Cash Flow 2022: $280.36M
2022's free cash flow for Bio-Techne came in at $280.36M, declined 8.9% below 2021.
Bio-Techne Free Cash Flow 2021: $307.86M
Bio-Techne free cash flow in 2021 was $307.86M.
See more financial history for Bio-Techne (TECH).
Sector peers by Free Cash Flow
Healthcare peers of Bio-Techne (TECH), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation